RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Cash from financing

RESMED INC【RMD】

Market cap
$37B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Jun 30, 2025-606-45.84%
Jun 30, 2024-1,119-364.69%
Jun 30, 2023423-429.44%
Jun 30, 2022-128-83.21%
Jun 30, 2021-765+140.99%
Jun 30, 2020-317-154.64%
Jun 30, 2019581-156.55%
Jun 30, 2018-1,027+290.58%
Jun 30, 2017-263-142.91%
Jun 30, 2016613-339.49%
Jun 30, 2015-256-13.97%
Jun 30, 2014-297+93.15%
Jun 30, 2013-154-13.09%
Jun 30, 2012-177+123.21%
Jun 30, 2011-79

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)